Pharvaris NV (PHVS) stock: key figures, P/E, revenue and dividend
Health Care · Netherlands · ISIN NL00150005Y4
Pharvaris NV financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Gross profit | 0.00 USD |
| Operating income | -196.53 m USD |
| EBIT | -228.38 m USD |
| Net income | -198.78 m USD |
| Diluted EPS – continuing operations | -3.63 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Pharvaris NV
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
More stocks
- Modivo SA (MDV.WA)
- Vale Indonesia Tbk (INCO.JK)
- Shenzhen Overseas Chinese Town Co Ltd (000069.SZ)
- Autel Intelligent Technology Corp Ltd (688208.SS)
- Vir Biotechnology, Inc. (VIR)
- Beijing Worldia Diamond Tools Co Ltd (688028.SS)
- Hangzhou Zhongheng Electric Co Ltd (002364.SZ)
- DIEBOLD NIXDORF, Inc (DBD)
- PLUG POWER INC (PLUG)
- MONARCH CASINO & RESORT INC (MCRI)
- Chemours Co (CC)
- SmartStop Self Storage REIT, Inc. (SMA)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.